Physician

Jeffrey Wayne Lantz, DO

According to 2025 Medicare claims, Jeffrey Lantz, DO (NPI: 1164929311) practices hematology/oncology in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (NPI: 1487621496; TIN: 541922084) and primary practice location at 24153-7474. Lantz is affiliated with the Sentara Accountable Care Organization, LLC (ACO ID: A4868), participating under the MSSP model.

Lantz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 27 traditional Medicare patients, billed 27 HCPCS/CPT codes, and received $2,503 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 42 prescription claims across 17 beneficiaries totaling $9,812 in drug costs. 2022 DME data shows 22 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $3,942 to $9,812. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$5.8K$12K2021 Medicare payment: $11,605 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $9,624 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,503 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202172151$11,605
202276149$9,624
2023N/RN/RN/R
20242727$2,503

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$25K$50K2019 Drug cost: $3,942 (USD; Tot_Drug_Cst)2020 Drug cost: $50,423 (USD; Tot_Drug_Cst)2021 Drug cost: $42,259 (USD; Tot_Drug_Cst)2022 Drug cost: $6,749 (USD; Tot_Drug_Cst)2023 Drug cost: $7,710 (USD; Tot_Drug_Cst)2024 Drug cost: $9,812 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20192449$3,942
202036531$50,423
202157575$42,259
202232101$6,749
20231430$7,710
20241742$9,812

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$601$1.2K2022 Medicare payment: $1,202 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R22$1,202
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes1313$108
99221Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes1212$68

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Jeffrey Wayne Lantz, DO?

Tedicare shows public-source Medicare data for Jeffrey Wayne Lantz, DO (NPI 1164929311), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Wayne Lantz, DO have ACO affiliation data?

Jeffrey Wayne Lantz, DO is shown with ACO affiliation data for Sentara Accountable Care Organization, LLC (MSSP, ACO ID A4868).

What billing organization is linked to Jeffrey Wayne Lantz, DO?

Jeffrey Wayne Lantz, DO is linked to ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (billing NPI 1487621496) in the available physician profile data.

Does Jeffrey Wayne Lantz, DO have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.